International Medical Vice President, Obesity

Are you a medical and scientific expert working within the field of Obesity and Cardiometabolic diseases? Are you passionate about finding new treatments for people living with obesity?  Would you like to work for an organisation that has an unwavering dedication to improving the lives of people living with Obesity and other serious chronic diseases? If so, then this opportunity could be for you!

We are seeking an International Medical Vice President (IMVP) who will provide expert guidance on all aspects of clinical and scientific drug development within Obesity area. This is a pivotal role in securing Novo Nordisk's leadership position within Obesity and enabling further advancements of our differentiated portfolio of Obesity treatments. The role offers an exciting opportunity to join an industry-leading team of ambitious and highly dedicated medical and drug development experts.
 

The preferred location for this role is Denmark, Greater Copenhagen area. Other European or US locations could be considered, in which case frequent travel and alignment with CET work hours will be required.

The role

Reporting to the Vice President for Medical & Science, Obesity the IMVP is a central role that collaborates with various stakeholders across the organisation in a complex matrix setting. As a key opinion leader on Obesity, the IMVP represents Novo Nordisk at industry events, government working groups and in interactions with authorities.

The key responsibilities of International Medical Vice President, include:

• Driving medical and clinical aspects of the Obesity therapy area strategy within Novo Nordisk, ensuring state-of-the-art clinical development, implementation, and operationalizability.
• Providing projects in clinical drug development with medical expertise within Obesity including insights into current and new diagnostics, biomarkers, treatment modalities, translational medicine, and digital health solutions. This also includes supporting your Medical & Science colleagues with development of reports and protocols through offering valuable therapy area input.
• Support internal medical expert groups in securing scientifically sound medical deliverables and ensuring cross-project and cross-functional input, alignment, and implementation.
• Ensuring exploration, knowledge sharing, and alignment of medical and scientific topics across all the therapy areas within Novo Nordisk  
• Driving innovation and raising the innovation bar for the new and existing treatments
• Representing Novo Nordisk Clinical Development with Health authorities, academia, industry collaborative meetings and private-public partnerships. 

Qualifications:

We are looking for a medical and scientific leader with the following qualifications and skills:

• MD degree, PhD, and a Board-certified specialist with an extensive clinical and medical background within Obesity.
• Proven clinical experience coupled with involvement in clinical trials (own research or as principal investigator) as well as basic research understanding and solid drug development knowledge.
• Several years’ experience in academia. Experience with pharma, biotech or recognised KOL will be an advantage.
• A team player with a strong focus on collaboration and supporting the common goal
• Ability to navigate a complex matrix setting in a global pharma company and manage wide range of diverse external stakeholder interactions.
• A proactive, innovative, and solution-oriented mindset and ability to drive innovation and change.
• Excellent communication and presentation skills coupled with ability to make yourself understood by different audiences.

The Department:

Medical & Science, Obesity is a high impact area in Novo Nordisk. The area is anchored in Clinical Development & Project Leadership organisation and provides medical and scientific leadership for obesity, overseeing strategy development, project execution, and reporting for drug and device development. The department responsibility includes preparing and executing clinical trials, offering medical expertise to various functional areas, and representing Novo Nordisk in multiple forums. Medical & Science Obesity ensures the delivery of high-quality medical content for clinical documents, supports regulatory approval processes, and develops expert reports and clinical evaluations. The goal of the area is to develop a differentiated portfolio of medications and complementary therapeutic solutions for patients living with obesity. 

Working at Novo Nordisk

Novo Nordisk is a leading global healthcare company with a 100-year legacy of driving change to defeat serious chronic diseases. Building on our strong legacy within diabetes, we are growing massively and expanding our commitment, reaching millions around the world and impacting more than 40 million patient lives daily. All of this has made us one of the 20 most valuable companies in the world by market cap. Our success relies on the joint potential and collaboration of our more than 63,000 employees around the world. We recognise the importance of the unique skills and perspectives our people bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk, we're working toward something bigger than ourselves, and it's a collective effort. Join us! Together, we go further. Together, we're life changing.

Deadline

We look forward to receiving your application latest by January 12, 2025

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. 

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.